| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | 0.4 | 1e-07 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | -0.16 | 2e-05 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.16 | 8e-05 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.2 | 0.0002 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.0003 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | -0.2 | 0.0005 |
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | -0.19 | 0.0006 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0006 |
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0008 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0008 |